Expand APGE Menu
APGE MENU

APGE Latest Press Releases

-- September 3, 2026 --

AbbVie Completes Acquisition of Apogee Therapeutics PRNewswire 8:35 AM

-- August 10, 2026 --

Apogee Reports Second Quarter 2026 Financial Results and Recent Corporate and Pipeline Updates Globe Newswire 7:00 AM

-- July 31, 2026 --

Are DSGR, AVB, SLP, APGE Obtaining Fair Deals for their Shareholders? PRNewswire 11:02 AM

-- July 30, 2026 --

Apogee Therapeutics Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Apogee Therapeutics, Inc. - APGE Business Wire 12:07 PM

-- July 14, 2026 --

Halper Sadeh LLC is Investigating Whether NEE, CRBG, RMAX, APGE are Obtaining Fair Deals for their Shareholders Globe Newswire 6:55 PM
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--CRBG, RMAX, GBCS, and APGE PRNewswire 4:00 PM

-- July 6, 2026 --

Are AVB, LPRO, APGE, TMHC Obtaining Fair Deals for their Shareholders? PRNewswire 8:02 PM
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--AVB, APGE, TMHC, and LPRO PRNewswire 2:18 PM

-- July 2, 2026 --

Are APGE, INVE, CBAN, FSRL Obtaining Fair Deals for their Shareholders? PRNewswire 3:38 PM
Shareholder Alert: Ademi LLP investigates whether Apogee Therapeutics is obtaining a Fair Price for Public Shareholders Globe Newswire 5:34 AM

-- June 25, 2026 --

Are TECH, APGE, BOLD, REFI Obtaining Fair Deals for their Shareholders? PRNewswire 1:53 PM

-- June 24, 2026 --

Apogee Therapeutics Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Apogee Therapeutics, Inc. - APGE Business Wire 2:25 PM

-- June 23, 2026 --

Halper Sadeh LLC is Investigating Whether APGE, LPRO, HUN, AVNS are Obtaining Fair Deals for their Shareholders Globe Newswire 9:20 PM

-- June 22, 2026 --

Are ACA, CZR, APGE Obtaining Fair Deals for their Shareholders? PRNewswire 4:20 PM
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Apogee Therapeutics, Inc. (NASDAQ: APGE) PRNewswire 2:59 PM
Shareholder Alert: Ademi LLP investigates whether Apogee Therapeutics is obtaining a Fair Price for Public Shareholders PRNewswire 11:35 AM
APGE Stock Alert: Halper Sadeh LLC is Investigating Whether Apogee Therapeutics, Inc. is Obtaining a Fair Price for its Shareholders Business Wire 9:22 AM
AbbVie to Acquire Apogee Therapeutics, Deepening Immunology Portfolio PRNewswire 7:00 AM

-- May 28, 2026 --

Apogee Therapeutics to Participate in Upcoming June Conferences Globe Newswire 4:01 PM

-- May 27, 2026 --

Apogee Therapeutics Announces $1.3 Billion Strategic Financing Collaboration with Blackstone Life Sciences to Advance Phase 3 Development and Commercialization of Zumilokibart Globe Newswire 6:31 AM
Apogee Therapeutics Announces Positive 16-Week Part B Induction Dose Optimization Results from Phase 2 APEX Trial of Zumilokibart in Moderate-to-Severe Atopic Dermatitis Globe Newswire 6:30 AM

-- May 26, 2026 --

Apogee Therapeutics to Host Conference Call to Report Part B 16-Week Data from the Phase 2 APEX Trial of Zumilokibart in Patients with Moderate-to-Severe Atopic Dermatitis on May 27, 2026 Globe Newswire 4:01 PM

-- May 11, 2026 --

Apogee Therapeutics Provides Pipeline Progress and Reports First Quarter 2026 Financial Results Globe Newswire 7:00 AM
Market Data Delayed 15 Minutes